dexmedetomidine has been researched along with concanavalin a in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bo, L; Hu, B; Li, J; Luo, Y; Wang, H; Wang, J; Zou, Y | 1 |
| Kohane, DS; McAlvin, JB; Santamaria, CM; Wang, W; Zhan, C | 1 |
2 other study(ies) available for dexmedetomidine and concanavalin a
| Article | Year |
|---|---|
Dexmedetomidine premedication attenuates concanavalin A-induced hepatitis in mice.
Topics: Adrenergic alpha-2 Receptor Agonists; Animals; CD4-Positive T-Lymphocytes; Chemical and Drug Induced Liver Injury, Chronic; Chemokine CXCL10; Concanavalin A; Cytokines; Dexmedetomidine; Inflammation Mediators; Liver; Male; Mice; Mice, Inbred C57BL; NF-kappa B; Phosphorylation | 2014 |
Long-acting liposomal corneal anesthetics.
Topics: Administration, Topical; Anesthetics, Local; Animals; Concanavalin A; Cornea; Corneal Keratocytes; Dexmedetomidine; Liposomes; Male; Rats; Rats, Sprague-Dawley; Tetrodotoxin; Wound Healing | 2018 |